Skip to main content
Clinical Trials/NL-OMON35011
NL-OMON35011
Recruiting
Not Applicable

A prospective, descriptive cohort study evaluating the prevalence and incidence of exocrine pancreatic insufficiency in patients with pancreatic cancer. - Prevalence, incidence of EPI in pancreaticcancer

Academisch Medisch Centrum0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are considered for this trial:
  • \- Age \>\= 18 years.
  • \- Malignant tumours of the pancreas, distal cholangiocarcinoma and papillary tumours proven by means of cytology/histology and/or radiology.
  • \- are capable and willing to follow instructions given by the physician.

Exclusion Criteria

  • The following are considered as exclusion criteria:
  • \- Subjects who are unwilling or unable to understand and participate in the study and sign the informed consent.
  • \- Pre\-existent EPI
  • \- Pre\-existent malabsorption (short bowel disease, IBD, other)
  • \- Any known gastro\-intestinal disease or major gastrointestinal surgery that could potentially affect the intestinal absorption or metabolism of fat
  • \- Total pancreatectomy
  • \- Gastroparesis
  • \- Pregnancy/lactation
  • \- Patients who are suspected not to be reliable in participating in this study, based on the physicians experience.

Outcomes

Primary Outcomes

Not specified

Similar Trials